$Cadrenal Therapeutics (CVKD.US)$ Current Price target: Nobl...
$Cadrenal Therapeutics (CVKD.US)$ Current Price target:
Noble Capital Markets Initiates Coverage on Cadrenal Therapeutics with Outperform Rating and US$4.00 Price Target
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
I don't acknowledge Bashers anymore! They Will be Blocked They're a waste of Time!
1389Followers
489Following
12KVisitors
Follow